Patients affected by chronic dermatoses are at high risk for the developmen
t of sensitization to corticosteroids, This study was carried out to evalua
te contact hypersensitivity to corticosteroids in a selected group of patie
nts affected by longlasting cutaneous dermatoses, Sixty subjects underwent
the GIRDCA series. The Italian GIRDCA series we applied had the following s
ubstances in addition to the European standard series: imidazolidinyl urea
2% pet, thiomersal 0.1% pet, disperse yellow 31% pet, disperse red 1% pet,
4'4-diaminodiphenylmethane 0.5 % pet, ammoniated mercury 1% pet. The patien
ts were tested with our corticosteroids series and some of them also with t
heir own steroid products. Allergic reactions to corticosteroids were obser
ved in 8/60 (13.3%) patients; budesonide was the main sensitizer (7 positiv
es) followed by hydrocortisone-17-butyrate and betamethasone-17-valerate (2
and 1 positives, respectively). One patient also reacted to methylpredniso
lone aceponate contained in her own cream. 4/8 positives were certainly rel
ated to previous drug-exposure.
This study showed a very high percentage of sensitization to corticosteroid
s, In our opinion, this value may be due both to our selection-standards an
d to the wide employment of a well known sensitizer like budesonide in our
country. Although a corticosteroids series like ours seems to be adequate f
or the detection of sensitized patients, patch tests with individual compou
nds and/or steroids corresponding to local prescription habits are recommen
ded, especially in unresponsive chronic dermatoses.